The present single center retrospective study compared the survival of liver transplant recipients from anti-HBc positive and anti-HBc negative donors, described cases of de novo hepatitis B and hepatitis B reactivation and mortality-related variables. This evidence concerns the gene KRT88P and hepatitis B virus infection.